menu
    • menu

    Find Megestrol Acetate manufacturers, exporters & distributors on PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Coral Megestrol Acetate

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    pfizer centreone megestrol acetate

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    26

    API Suppliers

    API Suppliers

    14

    USDMF

    US DMFs Filed

    8

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    3

    KDMF

    KDMF

    6

    NDC API

    NDC API

    0

    VMF

    NDC API

    10

    Listed Suppliers

    Other Suppliers

    1INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    6

    EDQM

    0

    USP

    0

    JP

    3

    Others

    FINISHED DOSAGE FORMULATIONS

    65

    FDF Dossiers

    FDF Dossiers

    21

    FDA Orange Book

    FDA (Orange Book)

    25

    Europe

    Europe

    2

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    17

    Listed Dossiers

    Listed Dossiers

    13DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    225RELATED EXCIPIENT COMPANIES

    371EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 10,356

    GLOBAL SALES INFORMATION

    US Medicaid

    35,381,780

    Annual Reports

    NA

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    5

    API

    4

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    9

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 595-33-5, Megace, Megace es, Niagestin, Megestryl acetate, Megeron
    Molecular Formula
    C24H32O4
    Molecular Weight
    384.5  g/mol
    InChI Key
    RQZAXGRLVPAYTJ-GQFGMJRRSA-N
    FDA UNII
    TJ2M0FR8ES
    Megestrol Acetate
    Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
    1 2D Structure

    Megestrol Acetate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
    2.1.2 InChI
    InChI=1S/C24H32O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h12-13,18-20H,6-11H2,1-5H3/t18-,19+,20+,22-,23+,24+/m1/s1
    2.1.3 InChI Key
    RQZAXGRLVPAYTJ-GQFGMJRRSA-N
    2.1.4 Canonical SMILES
    CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C
    2.1.5 Isomeric SMILES
    CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
    2.2 Other Identifiers
    2.2.1 UNII
    TJ2M0FR8ES
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acetate, Megestrol

    2. Apo Megestrol

    3. Apo-megestrol

    4. Apomegestrol

    5. Borea

    6. Lin Megestrol

    7. Lin-megestrol

    8. Linmegestrol

    9. Maygace

    10. Megace

    11. Megefren

    12. Megestat

    13. Megostat

    14. Mestrel

    15. Nu Megestrol

    16. Nu-megestrol

    17. Numegestrol

    2.3.2 Depositor-Supplied Synonyms

    1. 595-33-5

    2. Megace

    3. Megace Es

    4. Niagestin

    5. Megestryl Acetate

    6. Megeron

    7. Megestat

    8. Ovaban

    9. Ovarid

    10. Maygace

    11. Pallace

    12. Bdh 1298

    13. Magestin

    14. Sc 10363

    15. Nsc-71423

    16. Volidan

    17. Sc10363

    18. 17alpha-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate

    19. Megesterol Acetate

    20. 17alpha-acetoxy-6-dehydro-6-methylprogesterone

    21. 6-dehydro-6-methyl-17alpha-acetoxyprogesterone

    22. 6-methyl-6-dehydro-17alpha-acetoxyprogesterone

    23. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate

    24. 17-acetoxy-6-methylpregna-4,6-diene-3,20-dione

    25. Sc-10363

    26. 17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione

    27. Bdh-1298

    28. 6-methyl-17alpha-hydroxy-delta(sup 6)-progesterone Acetate

    29. Tj2m0fr8es

    30. [(8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthren-17-yl] Acetate

    31. Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-

    32. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate

    33. Megestrol 17.alpha.-acetate

    34. Mls000028633

    35. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate

    36. Bdh1298

    37. Smr000058691

    38. Dsstox_cid_20683

    39. Dsstox_rid_79539

    40. Dsstox_gsid_40683

    41. Megestil

    42. 6-methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione

    43. Ovaban (veterinary)

    44. 6-methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone

    45. Megestrolacetate

    46. 6-methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione Acetate

    47. Megestrol Acetate [usan]

    48. (8xi,9xi,10xi,13xi,14xi)-6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate

    49. Ccris 372

    50. Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, Acetate

    51. Megestrol-17-acetate

    52. Einecs 209-864-5

    53. Unii-tj2m0fr8es

    54. Megestin

    55. Megestrol Acetole [progestins]

    56. Megestrol Acetate [usan:usp]

    57. Megestrol Acetole

    58. Megestrol-acetate

    59. 17-alpha-acetoxy-6-dehydro-6-methylprogesterone

    60. 6-dehydro-6-methyl-17-alpha-acetoxyprogesterone

    61. 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone

    62. Ncgc00016516-01

    63. (8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate

    64. Cas-595-33-5

    65. Megace (tn)

    66. 17alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione

    67. 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione

    68. 6-methyl-17-alpha-hydroxy-delta(sup 6)-progesterone Acetate

    69. 6-methyl-6-dehydro-17.alpha.-acetylprogesterone

    70. 6-methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone

    71. 6-methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione Acetate

    72. 17.alpha.-acetoxy-6-dehydro-6-methylprogesterone

    73. 6-dehydro-6-methyl-17.alpha.-acetoxyprogesterone

    74. 6-methyl-6-dehydro-17.alpha.-acetoxyprogesterone

    75. Megestrol Acetate (usp)

    76. Opera_id_1511

    77. Prestwick0_000956

    78. Prestwick1_000956

    79. Prestwick2_000956

    80. Prestwick3_000956

    81. 6-methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione Acetate

    82. Schembl745

    83. Bspbio_000952

    84. Mls000759501

    85. Mls001074091

    86. Mls001424055

    87. Par-100,2

    88. Spbio_003101

    89. Megestrol Acetate [mi]

    90. Bpbio1_001048

    91. Chebi:6723

    92. Chembl1201139

    93. Dtxsid9040683

    94. Megestrol Acetate [vandf]

    95. Megestrol Acetate [mart.]

    96. Bcpp000168

    97. Hms1570p14

    98. Hms2051i20

    99. Hms2090n04

    100. Hms2097p14

    101. Hms2235d16

    102. Hms3714p14

    103. Megestrol Acetate [usp-rs]

    104. Megestrol Acetate [who-dd]

    105. Megestrol Acetate [who-ip]

    106. Nia

    107. Nsc71423

    108. Zinc4097467

    109. Tox21_110469

    110. Tox21_302360

    111. Lmst02030118

    112. Mfcd00056470

    113. S1304

    114. Akos015894927

    115. Megestrol Acetate [green Book]

    116. Tox21_110469_1

    117. Bcp9000904

    118. Ccg-100899

    119. Cs-2065

    120. Db00351

    121. Megestrol Acetate [orange Book]

    122. Nc00149

    123. Megestrol Acetate [ep Monograph]

    124. 17-acetoxy-6-methylpregna-4,20-dione

    125. Megestrol Acetate [usp Monograph]

    126. Ncgc00024196-03

    127. Ncgc00024196-05

    128. Ncgc00255456-01

    129. Ac-24570

    130. As-13384

    131. Hy-13676

    132. 17.alpha.-acetoxy-6-methyl-4,20-dione

    133. Ab00490013

    134. B1377

    135. 17-hydroxy-6-methylpregna-4,20-dione Acetate

    136. 17.alpha.-acetoxy-6-methylpregna-4,20-dione

    137. C08151

    138. D00952

    139. D91560

    140. Ab00383046-13

    141. Ab00383046-14

    142. Ab00383046-15

    143. Ab00383046_16

    144. Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-

    145. 595m335

    146. A832354

    147. Megestrol-17-acetate 1000 Microg/ml In Methanol

    148. Sr-01000000258

    149. Megestrol-17-acetate 100 Microg/ml In Acetonitrile

    150. Pregna-4,20-dione, 17-hydroxy-6-methyl-, Acetate

    151. Q-201346

    152. Q6808975

    153. Sr-01000000258-4

    154. Brd-k19507340-001-03-1

    155. Medroxyprogesterone Acetate Impurity G [who-ip]

    156. Megestrol Acetate, Vetranal(tm), Analytical Standard

    157. Megestrol-17-acetate 100 Microg/ml In Methanol/water

    158. 17alpha-acetoxy-6-methyl-4,6-pregnadiene-3,20-dione

    159. Megestrol Acetate, Analytical Standard, For Drug Analysis

    160. Medroxyprogesterone Acetate Impurity G [ep Impurity]

    161. Wln: L E5 B666 Ov Ku Mutj A1 E1 Fv1 Fov1 L1

    162. 6-methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone Acetate

    163. Megestrol Acetate, European Pharmacopoeia (ep) Reference Standard

    164. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate [who-ip]

    165. Megestrol Acetate, United States Pharmacopeia (usp) Reference Standard

    166. Megesgtrol Acetate, Pharmaceutical Secondary Standard; Certified Reference Material

    167. Megestrol Acetate For Peak Identification, European Pharmacopoeia (ep) Reference Standard

    168. Megestrol Acetate For System Suitability, European Pharmacopoeia (ep) Reference Standard

    2.4 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 384.5 g/mol
    Molecular Formula C24H32O4
    XLogP33.1
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count3
    Exact Mass384.23005950 g/mol
    Monoisotopic Mass384.23005950 g/mol
    Topological Polar Surface Area60.4 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity821
    Isotope Atom Count0
    Defined Atom Stereocenter Count6
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 6  
    Drug NameMegace
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6...
    Active IngredientMegestrol acetate
    Dosage FormSuspension
    RouteOral
    Strength40mg/ml
    Market StatusPrescription
    CompanyBristol Myers Squibb

    2 of 6  
    Drug NameMegace es
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMegace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3...
    Active IngredientMegestrol acetate
    Dosage FormSuspension
    RouteOral
    Strength125mg/ml
    Market StatusPrescription
    CompanyPar Pharm

    3 of 6  
    Drug NameMegestrol acetate
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMegestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL...
    Active IngredientMegestrol acetate
    Dosage FormTablet; Suspension
    RouteOral
    Strength125mg/ml; 40mg/ml; 40mg; 20mg
    Market StatusPrescription
    CompanyTwi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr

    4 of 6  
    Drug NameMegace
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6...
    Active IngredientMegestrol acetate
    Dosage FormSuspension
    RouteOral
    Strength40mg/ml
    Market StatusPrescription
    CompanyBristol Myers Squibb

    5 of 6  
    Drug NameMegace es
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMegace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3...
    Active IngredientMegestrol acetate
    Dosage FormSuspension
    RouteOral
    Strength125mg/ml
    Market StatusPrescription
    CompanyPar Pharm

    6 of 6  
    Drug NameMegestrol acetate
    PubMed HealthMegestrol Acetate (By mouth)
    Drug ClassesEndocrine-Metabolic Agent
    Drug LabelMegestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL...
    Active IngredientMegestrol acetate
    Dosage FormTablet; Suspension
    RouteOral
    Strength125mg/ml; 40mg/ml; 40mg; 20mg
    Market StatusPrescription
    CompanyTwi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr

    4.2 Drug Indication

    For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used for the palliative management of recurrent, inoperable, or metastatic breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.

    FDA Label

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. These effects include induction of secretory changes in the endometrium, increase in basal body temperature, pituitary inhibition, and production of withdrawal bleeding in the presence of estrogen. Mestrogel has slight glucocorticoid activity and very slight mineralocorticoid activity. This drug has no estrogenic, androgenic, or anabolic activity. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.

    5.2 MeSH Pharmacological Classification

    Antineoplastic Agents, Hormonal

    Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)

    Appetite Stimulants

    Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS. (See all compounds classified as Appetite Stimulants.)

    5.3 FDA Pharmacological Classification
    5.3.1 Pharmacological Classes
    Progestin [EPC]; Progesterone Congeners [CS]
    5.4 Absorption, Distribution and Excretion

    Absorption

    Variable, but well absorbed orally.

    Route of Elimination

    The major route of drug elimination in humans is urine. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces.

    5.5 Metabolism/Metabolites

    Primarily hepatic. Megestrol metabolites which were identified in urine constituted 5% to 8% of the dose administered. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces. No active metabolites have been identified.

    5.6 Biological Half-Life

    34 hours

    5.7 Mechanism of Action

    The precise mechanism by which megestrol acetate produces effects in anorexia and cachexia is unknown at the present time, but its progestin antitumour activity may involve suppression of luteinizing hormone by inhibition of pituitary function. Studies also suggest that the megestrol's weight gain effect is related to its appetite-stimulant or metabolic effects rather than its glucocorticoid-like effects or the production of edema. It has also been suggested that megestrol may alter metabolic pathyways via interferences with the production or action of mediators such as cachectin, a hormone that inhibits adipocyte lipogenic enzymes.

    USDMF

    read-more
    read-moreread-more

    01

    Farmabios Spa

    Germany
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAxplora is your partner of choice for complex APIs.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2021-03-25

    Pay. Date : 2021-03-22

    DMF Number : 12662

    Submission : 1997-09-20

    Status : Active

    Type : II

    Axplora CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Tapi Nl Bv

    Israel
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Contact Supplier Contact Supplier
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2012-11-29

    Pay. Date : 2012-11-09

    DMF Number : 12687

    Submission : 1997-10-08

    Status : Active

    Type : II

    TAPI Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bayer Schering Pharma Ag

    Germany

    USDMF

    arrow
    BIO Partnering at JPM
    Not Confirmed

    03

    Bayer Schering Pharma Ag

    Germany
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5296

    Submission : 1984-03-15

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Diosynth Bv

    United Kingdom

    USDMF

    arrow
    BIO Partnering at JPM
    Not Confirmed

    04

    Diosynth Bv

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7012

    Submission : 1987-06-09

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Diosynth Bv

    United Kingdom

    USDMF

    arrow
    BIO Partnering at JPM
    Not Confirmed

    05

    Diosynth Bv

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3869

    Submission : 1980-06-13

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Glaxo Laboratories Sa

    United Kingdom

    USDMF

    arrow
    BIO Partnering at JPM
    Not Confirmed

    06

    Glaxo Laboratories Sa

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 2494

    Submission : 1975-07-23

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Nv Organon

    U.S.A

    USDMF

    arrow
    BIO Partnering at JPM
    Not Confirmed

    07

    Nv Organon

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12157

    Submission : 1996-10-02

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    BIO Partnering at JPM
    Not Confirmed

    08

    Pharmacia And Upjohn Co Llc Wholly O...

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 1817

    Submission : 1971-11-21

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    BIO Partnering at JPM
    Not Confirmed

    09

    Societa Italiana Corticosteroidi Spa

    Italy
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 6673

    Submission : 1986-11-12

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    BIO Partnering at JPM
    Not Confirmed

    10

    Taizhou Taifa Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-03-31

    Pay. Date : 2014-10-31

    DMF Number : 24583

    Submission : 2011-01-26

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749234600,"product":"MEGESTROL ACETATE EP BATCH NO 2905A-00125 MFG DATE MAY, 2025 RETEST DATE APRIL,2028","address":"805, AKASH DEEP BUILDING","city":"NEW DELHI.","supplier":"CORAL DRUGS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MANCHESTER","customer":"TO ORDER","customerCountry":"UNITED KINGDOM","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"4500","totalValueFC":"269.6","currency":"USD","unitRateINR":231685,"date":"07-Jun-2025","totalValueINR":"23168.5","totalValueInUsd":"269.6","indian_port":"Delhi Air","hs_no":"29372900","bill_no":"2523485","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"805, AKASH DEEP BUILDING, NEW DELHI.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699468200,"product":"NOMEGESTROL ACETATE (BATCH NO.ND1116)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"NEWCHEM S P A","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"16788.6","totalValueFC":"33931.6","currency":"USD","unitRateINR":"1412756.5","date":"09-Nov-2023","totalValueINR":"2825513","totalValueInUsd":"33931.6","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29372300","bill_no":"1004595","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"VIA E.DE AMICIS 47 20123 ITALY 0","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706293800,"product":"NOMEGESTROL ACETATE (BATCH NO.ND1116)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"NEW CHEM S P A","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"14267.5","totalValueFC":"72186","currency":"USD","unitRateINR":"1199900","date":"27-Jan-2024","totalValueINR":"5999500","totalValueInUsd":"72186","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29372300","bill_no":"1000339","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"VIA E. DE AMICIS-47 20123 MILANO Italy","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"NOMEGESTROL ACETATE (BATCH NO.NE0732)","address":"","city":"","supplier":"NEW CHEM S P A","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"SENADOR LABORATORIES PRIVATE LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"14186.7","totalValueFC":"71649.4","currency":"USD","unitRateINR":"1196650","date":"06-Apr-2024","totalValueINR":"5983250","totalValueInUsd":"71649.4","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29372300","bill_no":"1001291","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"VIA E. DE AMICIS-47 20123 MILANO Italy","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722623400,"product":"NOMEGESTROL ACETATE (FOR R&D PURPOSE ONLY NOT FOR SALE VIDEIMPORT LIC.NO.SW\/OD\/11\/2024\/000003184 DT. 24.06.2024)","address":"D-158-A,OKHLA INDUSTRIAL AREA,","city":"NEW DELHI","supplier":"NEWCHEM S P A","supplierCountry":"ITALY","foreign_port":"MILAN","customer":"KUSUM HEALTHCARE PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"19800","totalValueFC":"2177.6","currency":"EURO","unitRateINR":"1826550","date":"03-Aug-2024","totalValueINR":"182655","totalValueInUsd":"2177.6","indian_port":"Delhi Air","hs_no":"29372300","bill_no":"4856876","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN","supplierAddress":"VIA SAN VITTORE 39 - 20123, MILANO,ITALYSDNF ITALY","customerAddress":"D-158-A,OKHLA INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733941800,"product":"NOMEGESTROL ACETATE (FOR R&D PURPOSE ONLY NOT FOR SALE VIDEIMPORT LIC.NO.SW\/OD\/11\/2024\/000003184 DT. 24.06.2024)NOMEGESTROL ACETATE (FOR R &D PURPOSE ONLY NOT FOR SALE VIDE","address":"D-158-A,OKHLA INDUSTRIAL AREA,","city":"NEW DELHI","supplier":"NEWCHEM S P A","supplierCountry":"ITALY","foreign_port":"MILAN","customer":"KUSUM HEALTHCARE PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"21002.1","totalValueFC":"2117","currency":"USD","unitRateINR":"1798830","date":"12-Dec-2024","totalValueINR":"179883","totalValueInUsd":"2117","indian_port":"Delhi Air","hs_no":"29372300","bill_no":"7189607","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN","supplierAddress":"VIA SAN VITTORE 39 - 20123, MILANO, ITALY SDNF ITALY","customerAddress":"D-158-A,OKHLA INDUSTRIAL AREA,"}]
    09-Nov-2023
    07-Jun-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

    Details:

    Megestrol Acetate is a small molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Cancer Cachexia.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Sponsor: Henan Cancer Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 21, 2025

    blank

    01

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Nutrition and Weight Loss

    Highest Development Status : Phase IV

    Partner/Sponsor/Collaborator : Henan Cancer Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With...

    Details : Megestrol Acetate is a small molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Cancer Cachexia.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    November 21, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

    Details:

    Megestrol Acetate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Tongji Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 02, 2025

    blank

    02

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Tongji Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small C...

    Details : Megestrol Acetate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 02, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Megestrol Acetate Efficacy and Safety In Preventing Chemotherapy-Induced Nausea/Vomiting

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Nausea.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Gastroenterology Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 19, 2025

    blank

    03

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Gastroenterology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Megestrol Acetate Efficacy and Safety In Preventing Chemotherapy-Induced Nausea/Vomiting

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Nausea.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 19, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study of MK-5684 in People with Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Details:

    MK-5684 is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Neoplasms.


    Lead Product(s): MK-5684,Fludrocortisone Acetate,Dexamethasone,Hydrocortisone,Fulvestrant,Exemestane,Megestrol Acetate,Medroxyprogesterone Acetate,Tamoxifen Citrate,

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 20, 2025

    blank

    04

    Merck & Co

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Merck & Co

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : MK-5684,Fludrocortisone Acetate,Dexamethasone,Hydrocortisone,Fulvestrant,Exemestane,Megestrol Acetate,Medroxyprogesterone Acetate,Tamoxifen Citrate,

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study of MK-5684 in People with Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Details : MK-5684 is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 20, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysi...

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Wuhan Union Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 07, 2025

    blank

    05

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Wuhan Union Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pr...

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 07, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in t...

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Small Cell Lung Carcinoma.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: West China Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 07, 2025

    blank

    06

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : West China Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for ...

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Small Cell Lung Carcinoma.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 07, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Fatigue-associated with Neoplasms.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 17, 2025

    blank

    07

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With C...

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Fatigue-associated with Neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    February 17, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Squamous Cell Carcinoma of Head and Neck.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 13, 2025

    blank

    08

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed

    GeneScience Pharmaceuticals Co Ltd

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell...

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Squamous Cell Carcinoma of Head and Neck.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 13, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Endometrial Neoplasms.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Ontario Institute for Cancer Research

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 18, 2022

    blank

    09

    Sunnybrook Health Sciences Centre

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Sunnybrook Health Sciences Centre

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Ontario Institute for Cancer Research

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Endometrial Neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    April 18, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT

    Details:

    Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Head and Neck Neoplasms.


    Lead Product(s): Megestrol Acetate,Inapplicable

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Chang Gung Memorial Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 02, 2016

    blank

    10

    TTY BIOPHARM CO LTD

    Taiwan
    arrow
    BIO Partnering at JPM
    Not Confirmed

    TTY BIOPHARM CO LTD

    Taiwan
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Megestrol Acetate,Inapplicable

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Chang Gung Memorial Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who...

    Details : Megestrol Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Head and Neck Neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    December 02, 2016

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    INTERMEDIATE SUPPLIERS

    read-more
    read-more

    01

    Pfizer CentreOne

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.

    Medroxyprogesterone acetate (2-MPB)

    CAS Number : 71-58-9

    End Use API : Megestrol Acetate

    About The Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and in...

    Pfizer centreOne

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    STRIDES PHARMA INTL

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 20MG

    Approval Date : 1988-08-08

    Application Number : 72422

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    STRIDES PHARMA INTL

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 40MG

    Approval Date : 1988-08-08

    Application Number : 72423

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    STRIDES PHARMA INTL

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : SUSPENSION;ORAL

    Dosage Strength : 40MG/ML

    Approval Date : 2001-07-25

    Application Number : 75671

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    BARR

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    BARR

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 40MG

    Approval Date : 1995-11-30

    Application Number : 74621

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    CHARTWELL

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    CHARTWELL

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : SUSPENSION;ORAL

    Dosage Strength : 125MG/ML

    Approval Date : 2017-12-01

    Application Number : 204688

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    HIKMA

    United Kingdom
    BIO Partnering at JPM
    Not Confirmed
    arrow

    HIKMA

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 20MG

    Approval Date : 1995-09-29

    Application Number : 74458

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HIKMA

    United Kingdom
    BIO Partnering at JPM
    Not Confirmed
    arrow

    HIKMA

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 40MG

    Approval Date : 1995-09-29

    Application Number : 74458

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    HIKMA

    United Kingdom
    BIO Partnering at JPM
    Not Confirmed
    arrow

    HIKMA

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : SUSPENSION;ORAL

    Dosage Strength : 40MG/ML

    Approval Date : 2017-06-09

    Application Number : 203960

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TWI PHARMS

    Taiwan
    BIO Partnering at JPM
    Not Confirmed
    arrow

    TWI PHARMS

    Taiwan
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : SUSPENSION;ORAL

    Dosage Strength : 125MG/ML

    Approval Date : 2014-08-27

    Application Number : 203139

    RX/OTC/DISCN : RX

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    USL PHARMA

    United Kingdom
    BIO Partnering at JPM
    Not Confirmed
    arrow

    USL PHARMA

    United Kingdom
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    MEGESTROL ACETATE

    Brand Name : MEGESTROL ACETATE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 20MG

    Approval Date : 1987-10-02

    Application Number : 70646

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Europe

    read-more
    read-more

    01

    Europharma Sweden Ab

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Europharma Sweden Ab

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Deregistered

    Registration Country : Sweden

    Megestrol Acetate

    Brand Name : Megace

    Dosage Form : Tablet

    Dosage Strength : 160mg

    Packaging :

    Approval Date : 04/11/2004

    Application Number : 20040916000446

    Regulatory Info : Deregistered

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Orifarm Ab

    Denmark
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Orifarm Ab

    Denmark
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Deregistered

    Registration Country : Sweden

    Megestrol Acetate

    Brand Name : Megace

    Dosage Form : Tablet

    Dosage Strength : 160mg

    Packaging :

    Approval Date : 17/11/2004

    Application Number : 20040916001023

    Regulatory Info : Deregistered

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Pharmacenter

    Hungary
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Pharmacenter

    Hungary
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Hungary
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : EU CTD Dossier Available

    Registration Country : Hungary

    Megestrol Acetate

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 160MG

    Packaging : 30 Tabs & 100 Tabs

    Approval Date :

    Application Number :

    Regulatory Info : EU CTD Dossier Available

    Registration Country : Hungary

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    SOPHOS BIOTECH SRL

    Italy
    BIO Partnering at JPM
    Not Confirmed
    arrow

    SOPHOS BIOTECH SRL

    Italy
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    Megestrol

    Brand Name : MEGEXIA

    Dosage Form : Tablets

    Dosage Strength : 160 mg

    Packaging : 30 UNITS 160 MG - ORAL USE

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Viatris Healthcare Limited

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Viatris Healthcare Limited

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Megestrol Acetate

    Brand Name : Borea

    Dosage Form : Tablet

    Dosage Strength : 160MG

    Packaging :

    Approval Date : 1991-07-01

    Application Number : 58775

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Viatris Healthcare Limited

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Viatris Healthcare Limited

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Megestrol Acetate

    Brand Name : Borea

    Dosage Form : Granule For Oral Suspension

    Dosage Strength : 160MG

    Packaging :

    Approval Date : 1998-07-01

    Application Number : 62011

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TEOFARMA Srl

    Country
    BIO Partnering at JPM
    Not Confirmed
    arrow

    TEOFARMA Srl

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    Megestrol Acetate

    Brand Name : Megestil

    Dosage Form : Megestrol 160Mg 30 Joined' Oral Use

    Dosage Strength : 30 CPR 160 mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    PHARMASWISS CESKA REPUBL.S.R.O

    Country
    BIO Partnering at JPM
    Not Confirmed
    arrow

    PHARMASWISS CESKA REPUBL.S.R.O

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    Megestrol Acetate

    Brand Name : Megace@

    Dosage Form : Megestrol 160Mg 30 Joined' Oral Use

    Dosage Strength : 30 CPR 160 mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Pharma Swiss Ceska republika s.r.o.

    Country
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Pharma Swiss Ceska republika s.r.o.

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Megestrol Acetate

    Brand Name : Megace

    Dosage Form : Antic-calc Tablet

    Dosage Strength : 160 mg

    Packaging : Blister

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    ISTITUTO GENTILI SRL

    Country
    BIO Partnering at JPM
    Not Confirmed
    arrow

    ISTITUTO GENTILI SRL

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Italy

    Megestrol

    Brand Name : GESTROLTEX

    Dosage Form : Tablets

    Dosage Strength : 160 mg

    Packaging : 30 UNITS 160 MG - ORAL USE

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Italy

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Dossiers

    read-more
    read-more

    01

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name : Megestrol Acetate

    Dosage Form : Tablet

    Dosage Strength : 20MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    01

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 20MG

    Brand Name : Megestrol Acetate

    Approval Date :

    Application Number :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name : Megestrol Acetate

    Dosage Form : Tablet

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 40MG

    Brand Name : Megestrol Acetate

    Approval Date :

    Application Number :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name : Megestrol Acetate

    Dosage Form : Oral Solution

    Dosage Strength : 40MG/ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Strides Pharma Science

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Oral Solution

    Dosage Strength : 40MG/ML

    Brand Name : Megestrol Acetate

    Approval Date :

    Application Number :

    Registration Country : India

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GetWell Pharmaceutical

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    GetWell Pharmaceutical

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name : MEGETRA

    Dosage Form : Tablet

    Dosage Strength : 40MG

    Packaging : 1X10 Tablets

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GetWell Pharmaceutical

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    GetWell Pharmaceutical

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging : 1X10 Tablets

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 40MG

    Brand Name : MEGETRA

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Madras Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Madras Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Madras Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Madras Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 40MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Madras Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Madras Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 160MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Madras Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Madras Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 160MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Swasthya Healthcare

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Swasthya Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Swasthya Healthcare

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Swasthya Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 40MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Swasthya Healthcare

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Swasthya Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name :

    Dosage Form : Tablet

    Dosage Strength : 160MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Swasthya Healthcare

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Swasthya Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 160MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    West-Coast Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    West-Coast Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : India

    Megestrol Acetate

    Brand Name : MESTROL

    Dosage Form : Tablet

    Dosage Strength : 40mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    West-Coast Pharmaceuticals

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    West-Coast Pharmaceuticals

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Tablet

    Dosage Strength : 40mg

    Brand Name : MESTROL

    Approval Date :

    Application Number :

    Registration Country : India

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Zhejiang Xianju Pharmaceutical Co. Ltd.

    China
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Zhejiang Xianju Pharmaceutical Co. Ltd.

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : China

    Megestrol Acetate

    Brand Name :

    Dosage Form : Dispersible Tablet

    Dosage Strength : 160MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : China

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Zhejiang Xianju Pharmaceutical Co. Ltd.

    China
    BIO Partnering at JPM
    Not Confirmed
    arrow

    Zhejiang Xianju Pharmaceutical Co. Ltd.

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Packaging :

    Regulatory Info :

    Megestrol Acetate

    Dosage : Dispersible Tablet

    Dosage Strength : 160MG

    Brand Name :

    Approval Date :

    Application Number :

    Registration Country : China

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - SUSPENSION;ORAL - 40MG/ML **Federal ...DOSAGE - SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 20264

    read-more

    DOSAGE - SUSPENSION;ORAL - 125MG/ML

    USFDA APPLICATION NUMBER - 21778

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    01

    SPI Pharma

    U.S.A
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Brand Name : CS90

    Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

    Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

    Pharmacopoeia Ref : NA

    Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85

    Ingredient(s) : Calcium Carbonate Excipient

    arrow
    SPI Pharma CS90

    Excipients Web Link

    Virtual Booth

    02

    EUROAPI

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Dosage Form : Tablet

    Grade : Oral

    Category : Fillers, Diluents & Binders

    Brand Name : Calcium Lactate-Glycerol Adduct

    Application : Fillers, Diluents & Binders

    Excipient Details : Calcium lactate-glycerol adduct is used both as a stabilizer and a binder in tablet formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Calcium Lactate

    arrow
    EUROAPI Calcium Lactate-Glycerol Adduct

    Excipients Web Link

    Virtual Booth

    03

    Rochem International Inc

    U.S.A
    arrow
    Suppliers Night Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Brand Name : Gum Arabic

    Application : API Stability Enhancers, Emulsifying Agents, Fillers, Diluents & Binders

    Excipient Details : Acacia, also known as gum arabic, is used in the pharmaceutical industry as an emulsifier, stabilizing agent, & tablet binder in various formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Gum Arabic

    arrow
    Gum Arabic

    Excipients Web Link

    Virtual Booth

    04

    Gangwal Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Tablet

    Grade : Oral

    Category : Co-Processed Excipients, Fillers, Diluents & Binders

    Brand Name : Starlose®

    Application : Co-Processed Excipients, Fillers, Diluents & Binders

    Excipient Details : Starlose P40 (Starch & Lactose Monohydrate) is used as a diluent in oral dosage forms such as tablets.

    Pharmacopoeia Ref : DMF, EXCiPAT, KOSHER, HALAL, W...

    Technical Specs : NA

    Ingredient(s) : Starch

    arrow
    Gangwal Healthcare Starlose®

    Excipients Web Link

    Virtual Booth

    05

    Nanjing Well Pharmaceutical

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Category : Parenteral

    Brand Name : Lactose Monohydrate

    Application : Parenteral

    Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Lactose Monohydrate

    arrow
    Nanjing Well Lactose Monohydrate

    Excipients Web Link

    Virtual Booth

    06

    Rochem International Inc

    U.S.A
    arrow
    Suppliers Night Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Brand Name : Carboxymethyl Cellulose

    Application : Coating Systems & Additives, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : Carboxymethylcellulose serves as a disintegrant, binder, coating agent & thickener in oral formulations, also as a stabilizer in topical formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Carboxymethyl Cellulose Sodium

    arrow
    Carboxymethyl Cellulose

    Excipients Web Link

    Virtual Booth

    07

    Gangwal Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Category : Co-Processed Excipients, Fillers, Diluents & Binders

    Brand Name : ProBlend®

    Application : Co-Processed Excipients, Fillers, Diluents & Binders

    Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.

    Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...

    Technical Specs : NA

    Ingredient(s) : Microcrystalline Cellulose Excipients

    arrow
    Gangwal Healthcare ProBlend®

    Excipients Web Link

    Virtual Booth

    08

    Gangwal Healthcare

    India
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Tablet

    Grade : Oral

    Category : Co-Processed Excipients, Fillers, Diluents & Binders

    Brand Name : Microlose™

    Application : Co-Processed Excipients, Fillers, Diluents & Binders

    Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.

    Pharmacopoeia Ref : DMF, EXCiPAT, KOSHER, HALAL, W...

    Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

    Ingredient(s) : Lactose Monohydrate

    arrow
    Gangwal Healthcare Microlose™

    Excipients Web Link

    Virtual Booth

    09

    Pluviaendo

    Turkey
    BIO Partnering at JPM
    Not Confirmed
    arrow

    10

    Pluviaendo

    Turkey
    BIO Partnering at JPM
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Coating Systems & Additives

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    01

    Pluviaendo

    Turkey
    BIO Partnering at JPM
    Not Confirmed
    arrow

    02

    Sigachi Industries

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    03

    Sigachi Industries

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow

    04

    Pharmatrans-Sanaq

    Switzerland
    BIO Partnering at JPM
    Not Confirmed
    arrow

    05

    Ingredion Pharma Solutions

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    06

    Kerry

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    07

    DFE Pharma

    Germany
    BIO Partnering at JPM
    Not Confirmed
    arrow

    08

    Pharmatrans-Sanaq

    Switzerland
    BIO Partnering at JPM
    Not Confirmed
    arrow

    09

    Kerry

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow

    10

    The Dow Chemical Company

    U.S.A
    BIO Partnering at JPM
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Controlled & Modified Release

    read-more
    read-more

    Topical

    read-more
    read-more

    01

    EUROAPI

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral

    Grade : Topical, Parenteral

    Category : Parenteral, Topical

    Brand Name : Purified Glycerin

    Application : Parenteral, Topical

    Excipient Details : Purified glycerin is used in topical dosage forms such as creams, lotions, and ointments. It is also used as a solvent in parenteral formulations.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Glycerol Excipient

    arrow
    ERUOAPI Purified Glycerin

    Excipients Web Link

    Virtual Booth

    02

    DKSH

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : XANTURAL® 11000

    Application : Rheology Modifiers, Thickeners and Stabilizers, Topical

    Excipient Details : Xantural 11000 is used as a stabilizer and rheology modifier in oral dosage forms such as syrups, suspensions & solutions & in topical formulations.

    Pharmacopoeia Ref : JP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Xanthan Gum

    arrow
    XANTURAL® 11000

    Excipients Web Link

    Virtual Booth

    03

    Nanjing Well Pharmaceutical

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Polysorbate 80

    Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Polysorbate 80

    arrow
    Polysorbate 80

    Excipients Web Link

    Virtual Booth

    04

    Pluviaendo

    Turkey
    BIO Partnering at JPM
    Not Confirmed
    arrow

    05

    Nanjing Well Pharmaceutical

    China
    arrow
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASK US

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Polyoxyethylene (35) Castor Oil

    Application : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Topical

    Excipient Details : Polyxyl 35 castor oil is used as surfactant & emulsifier in parenteral formulations. It acts as solubilizer & emulsifier in oral & topical products.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyoxyl 35 Castor Oil

    arrow
    Polyoxyethylene (35) Castor Oil

    Excipients Web Link

    Virtual Booth

    06

    DKSH

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

    Brand Name : XANTURAL® 180

    Application : Rheology Modifiers, Thickeners and Stabilizers, Topical

    Excipient Details : Xantural 180 is used as a rheology modifier & stabilizer in oral dosage forms such as solutions, suspensions, and syrups & in topical formulations.

    Pharmacopoeia Ref : JP, EP, USP/NF

    Technical Specs : N/A

    Ingredient(s) : Xanthan Gum

    arrow
    XANTURAL® 180

    Excipients Web Link

    Virtual Booth

    07

    Nanjing Well Pharmaceutical

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Polyethylene Glycol 400

    Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyethylene Glycol 400

    arrow
    Nanjing Well Polyethylene Glycol 400 NF

    Excipients Web Link

    Virtual Booth

    08

    Nanjing Well Pharmaceutical

    China
    arrow
    BIO Partnering at JPM
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Brand Name : Propylene Glycol

    Application : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical

    Excipient Details : Propylene glycol is used as a solvent & stabilizer in injections. It is also used in topical semi-solids & as a plasticizer in soft capsules.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Propylene Glycol

    arrow
    Nanjing Well Propylene Glycol

    Excipients Web Link

    Virtual Booth

    09

    Nanjing Bold Chemical

    China
    BIO Partnering at JPM
    Not Confirmed
    arrow

    10

    Valens Pharmachem

    India
    BIO Partnering at JPM
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    01

    Pluviaendo

    Turkey
    Biotech Showcase
    Not Confirmed
    arrow

    02

    Pluviaendo

    Turkey
    Biotech Showcase
    Not Confirmed
    arrow

    03

    Microlex e.U

    Austria
    Biotech Showcase
    Not Confirmed
    arrow

    04

    Nitika Pharmaceutical Specialities

    India
    Biotech Showcase
    Not Confirmed
    arrow

    05

    Silverline Chemicals

    India
    Biotech Showcase
    Not Confirmed
    arrow

    06

    Pharmatrans-Sanaq

    Switzerland
    Biotech Showcase
    Not Confirmed
    arrow

    07

    Microlex e.U

    Austria
    Biotech Showcase
    Not Confirmed
    arrow

    08

    Vasa Pharmachem

    India
    Biotech Showcase
    Not Confirmed
    arrow

    09

    Anhui Sunhere Pharmaceutical Excip...

    China
    Biotech Showcase
    Not Confirmed
    arrow

    10

    Microlex e.U

    Austria
    Biotech Showcase
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Rheology Modifiers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Enforcement Report - Week of November 21, 2018
    Enforcement Report - Week of November 21, 2018

    21 Nov 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-21-2018-1542783991.pdf

    FDA
    21 Nov 2018
    Share Share
    Enforcement Report - Week of September 12, 2018
    Enforcement Report - Week of September 12, 2018

    12 Sep 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=812201872739

    FDA
    12 Sep 2018
    Share Share
    Breckenridge Pharm's Generic Megestrol Acetate Receives Approval In US
    Breckenridge Pharm's Generic Megestrol Acetate Receives Approval In US

    06 Dec 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204688

    FDA
    06 Dec 2017
    Share Share
    Hi-Tech Pharmacal Generic Megestrol Acetate Receives Approval In US
    Hi-Tech Pharmacal Generic Megestrol Acetate Receives Approval In US

    13 Jun 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203960

    FDA
    13 Jun 2017
    Share Share
    Sobi gains commercial rights from Pharma Swiss
    Sobi gains commercial rights from Pharma Swiss

    07 Jan 2016

    // Malin Anderson NORDIC LIFE SCIENCE

    http://nordiclifescience.org/sobi-gains-commercial-rights-pharma-swiss/

    Malin Anderson NORDIC LIFE SCIENCE
    07 Jan 2016
    Share Share

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    korearepublicofnew.png
    Megestrol Acetate (1 MT/ annum - 2 MT/ annum) API needed in Korea [ENA12727]
    A pharmaceutical company based in Korea that deals in the development and manufacturing of APIs and finished dosage formulations is looking for suppliers of Megestrol Acetate (1 MT/ annum - 2 MT/ annum) API for commercial purpose. The suppliers must support this enquiry with DMF.
    16 Feb 2022

    Reply

    16 Feb 2022

    Reply text-arrow

    Reply Comment (10)

    16 Feb 2022

    Hungary.png
    Ph.Eur Grade Megestrol Acetate (800 kg/ annum) API needed in Hungary [ENA09654]
    A company that deals in selling pharmaceutical products in the area of oncology, urology and hospital injectables is looking for suppliers of Ph.Eur Grade Megestrol Acetate (800 kg/ annum) API for commercial purposes. The suppliers must support this enquiry with GMP.
    04 Feb 2021

    Reply

    04 Feb 2021

    Reply text-arrow

    Reply Comment (12)

    04 Feb 2021

    india-flag.png
    USP/BP Grade Megestrol Acetate API needed in India [ENA06829]
    A fast-growing pharmaceutical manufacturing company is looking for suppliers of USP/BP Grade Megestrol Acetate API. The required quantity is 5 kg for developmental purposes & the commercial quantity will be 50-100 kg.
    12 Mar 2020

    Reply

    12 Mar 2020

    Reply text-arrow

    Reply Comment (5)

    12 Mar 2020

    Bangladesh.png
    USP Grade Megestrol Acetate (2 kg) API needed in Bangladesh [ENA06561]
    Global Trade & Pharma Solution, a trading company that deals in medicinal products is looking for suppliers of USP Grade Megestrol Acetate (2 kg) API. The suppliers must support this enquiry with DMF & CoA. Interested suppliers can contact them via: gtps2019@gmail.com.
    13 Feb 2020

    Reply

    13 Feb 2020

    Reply text-arrow

    Reply Comment (4)

    13 Feb 2020

    Market Place
    Enquiry// Megestrol Acetate and Dexamethasone API needed in Bangladesh [ENA01102]
    Skyrun Corporation Ltd., a reliable trading house of pharmaceutical raw materials in Dhaka, Bangladesh is looking for suppliers of following APIs: 1) Megestrol Acetate...…----100kg CPT Dhaka by Air. 2) Dexamethasone Base----5kg CPT Dhaka by Air. Interested suppliers should contact Md. Imam Hossain (Emon) via Email: skyrun.kamrul@gmail.com.
    17 Jul 2018

    Reply

    17 Jul 2018

    Reply text-arrow

    Reply Comment (0)

    17 Jul 2018

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF DOSSIERS

    read-more
    read-more
    Ireland.png
    Megestrol Acetate (5 mg) Tablets needed in Ireland [ENA09299]
    One of the world's largest manufacturers of OTC self-care products and suppliers of infant formulas for the store brand market is looking for suppliers of Megestrol Acetate (5 mg) Tablets for veterinary purposes. The required quantity is 300,000 packs of 12 blisters/ strip. The suppliers must support this enquiry with EU Dossier.
    15 Dec 2020

    Reply

    15 Dec 2020

    Reply text-arrow

    Reply Comment (5)

    15 Dec 2020

    Russia-big.png
    Megestrol (40 mg/1 ml) suspension needed in Russia [ENA05232]
    Veya Investments Limited, a private oil and gas service company that provides customers with services and supplies of the highest quality equipment in the field of drilling, oil and gas production, energy, as well as in the field of engineering in the oil and gas industry is looking for suppliers of Megestrol (40 mg/1 ml) suspension in 240 ml bottle. The required quantity is about 10,000 units. Interested suppliers can contact them via Email: nechaeva@veyainvest.com.
    23 Sep 2019

    Reply

    23 Sep 2019

    Reply text-arrow

    Reply Comment (0)

    23 Sep 2019

    Market Place
    Enquiry// Megestrol Acetate suspensions (20000 units/year) needed in Hungary [ENA00625]
    Coldwell Pharma Bt, a company with 4th position in the market shares of oncology and AIDS products in Hungary is looking for suppliers of Megestrol Acetate suspensions (20000 units/year). Interested suppliers/manufacturers should contact Edit Kosa Email: info@coldwell.hu Tel: +36306259842.
    25 Dec 2017

    Reply

    25 Dec 2017

    Reply text-arrow

    Reply Comment (0)

    25 Dec 2017

    Market Place
    Enquiry// Various finished dosage formulations needed in Brunei Darussalam (Part 3/3) [ENA00445]
    True Fix Pvt. Ltd., an innovative sourcing and distribution company is searching for suppliers of following products for registration and distribution in Brunei Darussalam: 61. Letrozole 2.5mg (Femara) Tablet 50 Units 62. Lomustine 40mg (CCNU) Capsule 50 Units 63. Megestrol Acetate 160mg (Megaplex 160) Tablet 50 Units 64. Mesna 400mg/4mL Injection 50 Units 65. Methotrexate 1000mg Injection 100 Units 66. Methotrexate 50mg/2mL Injection 100 Units 67. Mitomycin 10mg Injection 50 Units 68. Mitomycin 2mg Injection 50 Units 69. Mitotane 500mg (Lysodren) Tablet 50 Units 70. Mitoxantrone 20mg/10mL Injection 50 Units 71. Oxaliplatin 100mg Injection 100 Units 72. Paclitaxel 100mg (Abraxane) Injection 100 Units 73. Paclitaxel 150mg Injection 100 Units 74. Paclitaxel 300mg Injection 100 Units 75. Pazopanib 200mg (Votrient) Tablet 100 Units 76. Pazopanib 400mg (Votrient) Tablet 100 Units 77. Pegfilgrastim 6mg/0.6mL Injection 100 Units 78. Pemetrexed 500mg (Alimta) Injection 100 Units 79. Procarbazine 50mg Capsule 50 Units 80. Regorafenib 40mg (Stivarga) Tablet 50 Units 81. Rituximab 500mg/50mL Injection 100 Units 82. Sorafenib 200mg (Nexavar) Tablet 100 Units 83. Sunitinib 12.5mg (Sutent) Capsule (Hard) 50 Units 84. Tamoxifen 20mg 30's Tablet 100 Units 85. Temozolomide 100mg (Temodal) Capsule 50 Units 86. Trabectedin 1mg (Yondelis) Injection 50 Units 87. Trastuzumab 440mg Injection 100 Units 88. Vinblastine 10mg/10mL Injection 100 Units 89. Vincristine 2mg/2mL Injection 100 Units 90. Vinorelbine 50mg/5mL Injection 50 Units 91. Zoledronic Acid 800mcg/mL 5mL (Zometa) Injection 100 Units Interested suppliers should contact Rizuan Ajik via Email: rizuan@truefixpharma.com or Tel: +673 7246880.
    09 Aug 2017

    Reply

    09 Aug 2017

    Reply text-arrow

    Reply Comment (1)

    09 Aug 2017

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    EDQM

    read-more
    read-more

    01

    EDQM, Council of Europe

    Nomegestrol acetate impurity A

    arrow
    BIO Partnering at JPM
    Not Confirmed

    01

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Nomegestrol acetate impurity A

    CAS Number : n/a

    Quantity Per Vial : 50 mg

    Sale Unit : 1

    Order Code : N1080005

    Batch No : 2

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    EDQM, Council of Europe

    Nomegestrol acetate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    02

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Nomegestrol acetate

    CAS Number : 58652-20-3

    Quantity Per Vial : 100 mg

    Sale Unit : 1

    Order Code : N1080000

    Batch No : 2

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    EDQM, Council of Europe

    Megestrol acetate for system suitability

    arrow
    BIO Partnering at JPM
    Not Confirmed

    03

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Megestrol acetate for system suitability

    CAS Number : 595-33-5

    Quantity Per Vial : 50 mg

    Sale Unit : 1

    Order Code : Y0001524

    Batch No : 2

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    EDQM, Council of Europe

    Megestrol acetate for peak identificatio...

    arrow
    BIO Partnering at JPM
    Not Confirmed

    04

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Megestrol acetate for peak identification

    CAS Number : 595-33-5

    Quantity Per Vial : 25 mg

    Sale Unit : 1

    Order Code : Y0001507

    Batch No : 1

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    EDQM, Council of Europe

    Megestrol acetate for impurity K identif...

    arrow
    BIO Partnering at JPM
    Not Confirmed

    05

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Megestrol acetate for impurity K identification

    CAS Number : n/a

    Quantity Per Vial : 0.01 mg

    Sale Unit : 1

    Order Code : Y0001594

    Batch No : 1

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    EDQM, Council of Europe

    Megestrol acetate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    06

    EDQM, Council of Europe

    France
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Megestrol acetate

    CAS Number : 595-33-5

    Quantity Per Vial : 120 mg

    Sale Unit : 1

    Order Code : Y0001514

    Batch No : 1

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ANALYTICAL

    Upload your methods for free, ask us

    ABOUT THIS PAGE

    Looking for 595-33-5 / Megestrol Acetate API manufacturers, exporters & distributors?

    Megestrol Acetate manufacturers, exporters & distributors 1

    67

    PharmaCompass offers a list of Megestrol Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Megestrol Acetate manufacturer or Megestrol Acetate supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Megestrol Acetate manufacturer or Megestrol Acetate supplier.

    PharmaCompass also assists you with knowing the Megestrol Acetate API Price utilized in the formulation of products. Megestrol Acetate API Price is not always fixed or binding as the Megestrol Acetate Price is obtained through a variety of data sources. The Megestrol Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Megestrol Acetate

    Synonyms

    595-33-5, Megace, Megace es, Niagestin, Megestryl acetate, Megeron

    Cas Number

    595-33-5

    Unique Ingredient Identifier (UNII)

    TJ2M0FR8ES

    About Megestrol Acetate

    Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

    Megace, Megace ES, Megestrol Acetate Manufacturers

    A Megace, Megace ES, Megestrol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Megace, Megace ES, Megestrol Acetate, including repackagers and relabelers. The FDA regulates Megace, Megace ES, Megestrol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Megace, Megace ES, Megestrol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Megace, Megace ES, Megestrol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Megace, Megace ES, Megestrol Acetate Suppliers

    A Megace, Megace ES, Megestrol Acetate supplier is an individual or a company that provides Megace, Megace ES, Megestrol Acetate active pharmaceutical ingredient (API) or Megace, Megace ES, Megestrol Acetate finished formulations upon request. The Megace, Megace ES, Megestrol Acetate suppliers may include Megace, Megace ES, Megestrol Acetate API manufacturers, exporters, distributors and traders.

    click here to find a list of Megace, Megace ES, Megestrol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Megace, Megace ES, Megestrol Acetate USDMF

    A Megace, Megace ES, Megestrol Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Megace, Megace ES, Megestrol Acetate active pharmaceutical ingredient (API) in detail. Different forms of Megace, Megace ES, Megestrol Acetate DMFs exist exist since differing nations have different regulations, such as Megace, Megace ES, Megestrol Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Megace, Megace ES, Megestrol Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Megace, Megace ES, Megestrol Acetate USDMF includes data on Megace, Megace ES, Megestrol Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Megace, Megace ES, Megestrol Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Megace, Megace ES, Megestrol Acetate suppliers with USDMF on PharmaCompass.

    Megace, Megace ES, Megestrol Acetate KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Megace, Megace ES, Megestrol Acetate Drug Master File in Korea (Megace, Megace ES, Megestrol Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Megace, Megace ES, Megestrol Acetate. The MFDS reviews the Megace, Megace ES, Megestrol Acetate KDMF as part of the drug registration process and uses the information provided in the Megace, Megace ES, Megestrol Acetate KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Megace, Megace ES, Megestrol Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Megace, Megace ES, Megestrol Acetate API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Megace, Megace ES, Megestrol Acetate suppliers with KDMF on PharmaCompass.

    Megace, Megace ES, Megestrol Acetate CEP

    A Megace, Megace ES, Megestrol Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Megace, Megace ES, Megestrol Acetate Certificate of Suitability (COS). The purpose of a Megace, Megace ES, Megestrol Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Megace, Megace ES, Megestrol Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Megace, Megace ES, Megestrol Acetate to their clients by showing that a Megace, Megace ES, Megestrol Acetate CEP has been issued for it. The manufacturer submits a Megace, Megace ES, Megestrol Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Megace, Megace ES, Megestrol Acetate CEP holder for the record. Additionally, the data presented in the Megace, Megace ES, Megestrol Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Megace, Megace ES, Megestrol Acetate DMF.

    A Megace, Megace ES, Megestrol Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Megace, Megace ES, Megestrol Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of Megace, Megace ES, Megestrol Acetate suppliers with CEP (COS) on PharmaCompass.

    Megace, Megace ES, Megestrol Acetate NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Megace, Megace ES, Megestrol Acetate as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Megace, Megace ES, Megestrol Acetate API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Megace, Megace ES, Megestrol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Megace, Megace ES, Megestrol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Megace, Megace ES, Megestrol Acetate NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Megace, Megace ES, Megestrol Acetate suppliers with NDC on PharmaCompass.

    Megace, Megace ES, Megestrol Acetate GMP

    Megace, Megace ES, Megestrol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Megace, Megace ES, Megestrol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Megace, Megace ES, Megestrol Acetate GMP manufacturer or Megace, Megace ES, Megestrol Acetate GMP API supplier for your needs.

    Megace, Megace ES, Megestrol Acetate CoA

    A Megace, Megace ES, Megestrol Acetate CoA (Certificate of Analysis) is a formal document that attests to Megace, Megace ES, Megestrol Acetate's compliance with Megace, Megace ES, Megestrol Acetate specifications and serves as a tool for batch-level quality control.

    Megace, Megace ES, Megestrol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Megace, Megace ES, Megestrol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Megace, Megace ES, Megestrol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Megace, Megace ES, Megestrol Acetate EP), Megace, Megace ES, Megestrol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Megace, Megace ES, Megestrol Acetate USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search